Sign Up to like & get
recommendations!
0
Published in 2021 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.01643-21
Abstract: At week 48 in the phase IIIb DAWNING study, the integrase strand transfer inhibitor (INSTI) dolutegravir plus 2 nucleoside reverse transcriptase inhibitors demonstrated superiority to ritonavir-boosted lopinavir in achieving virologic suppression in adults with HIV-1…
read more here.
Keywords:
integrase inhibitor;
dawning study;
integrase;
resistance ... See more keywords